Skip to Content

Amobarbital Pregnancy and Breastfeeding Warnings

Amobarbital is also known as: Amytal Sodium

Amobarbital Pregnancy Warnings

Amobarbital has been assigned to pregnancy category D by the FDA. Use of barbiturates during pregnancy has been associated with a higher incidence of fetal abnormalities. Neonatal barbiturate withdrawal symptoms have been reported in infants whose mothers took barbiturates during pregnancy. In addition, administration of sedative-hypnotic barbiturates during labor may cause respiratory depression in the newborn. There are no controlled data in human pregnancy. Patients who receive amobarbital during pregnancy should be advised of the potential hazard to the fetus.

See references

Amobarbital Breastfeeding Warnings

Amobarbital is excreted into human breast milk in small amounts and should be administered with caution to nursing mothers.

See references

References for pregnancy information

  1. "Product Information. Amytal Sodium (amobarbital)." Marathon Pharmaceuticals, Deerfield, IL.

References for breastfeeding information

  1. "Product Information. Amytal Sodium (amobarbital)." Marathon Pharmaceuticals, Deerfield, IL.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide